Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul 8;106(7):dju132.
doi: 10.1093/jnci/dju132. Print 2014 Jul.

Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials

Ronald C Chen  1 , Peter Chang  2 , Richard J Vetter  2 , Himansu Lukka  2 , William A Stokes  2 , Martin G Sanda  2 , Deborah Watkins-Bruner  2 , Bryce B Reeve  2 , Howard M Sandler  2
Affiliations

Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials

Ronald C Chen et al. J Natl Cancer Inst. .

Abstract

The National Cancer Institute (NCI) Symptom Management and Health-Related Quality of Life Steering Committee convened four working groups to recommend core sets of patient-reported outcomes to be routinely incorporated in clinical trials. The Prostate Cancer Working Group included physicians, researchers, and a patient advocate. The group's process included 1) a systematic literature review to determine the prevalence and severity of symptoms, 2) a multistakeholder meeting sponsored by the NCI to review the evidence and build consensus, and 3) a postmeeting expert panel synthesis of findings to finalize recommendations. Five domains were recommended for localized prostate cancer: urinary incontinence, urinary obstruction and irritation, bowel-related symptoms, sexual dysfunction, and hormonal symptoms. Four domains were recommended for advanced prostate cancer: pain, fatigue, mental well-being, and physical well-being. Additional domains for consideration include decisional regret, satisfaction with care, and anxiety related to prostate cancer. These recommendations have been endorsed by the NCI for implementation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flowchart of the selection process of articles for the literature review.
See this image and copyright information in PMC

Comment in

References

    1. Reeve B, Mitchell S, Dueck A, et al. Recommended core set of symptoms to measure adult oncology treatment trials. - PMC - PubMed
    1. Clark JA, Talcott JA. Symptom indexes to assess outcomes of treatment for early prostate cancer. Med Care. 2001;39(10):1118–1130 - PubMed
    1. Wei JT, Dunn RL, Litwin MS, et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899–905 - PubMed
    1. Litwin MS, Hays RD, Fink A, et al. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care. 1998;36(7):1002–1012 - PubMed
    1. Chang P, Szymanski KM, Dunn RL, et al. Expanded prostate cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer. J Urol. 2011;186(3):865–872 - PMC - PubMed

Publication types

MeSH terms